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Background: Glucagon stimulates liver 
respiration. 
Results: SCaMC-3 is the only functional 
mitochondrial ATP-Mg/Pi carrier in adult 
liver and SCaMC-3 deficiency prevents 
glucagon effects in hepatocytes and in vivo.  
Conclusion: SCaMC-3 is required for the 
stimulation of oxidative phosphorylation in 
response to glucagon through a Ca2+-
dependent increase of mitochondrial adenine 
nucleotides and Ca2+ retention. 
Significance: Ca2+-stimulation of SCaMC-3 
is required for liver response to glucagon. 
. 
SUMMARY 
It has been known for a long time 
that mitochondria isolated from 
hepatocytes treated with glucagon or Ca2+-
mobilising agents such as phenylephrine 
show an increase in their adenine 
nucleotide (AdN)1 content, respiratory 
                                                 
1 Abbreviations used are: AdN, adenine nucleotides; KO, 
knock-out; OXPHOS, oxidative phosphorylation; ANT, 
ATP/ADP translocase; RR, ruthenium red; SCaMC, short 
calcium-binding mitochondrial carrier; FCCP, Carbonyl 
cyanide-4-(trifluoromethoxy) phenylhydrazone; CRC, 
calcium retention capacity. 
 
activity and calcium retention capacity 
(CRC). Here, we have studied the role of 
SCaMC-3/slc25a23, the mitochondrial 
ATP-Mg/Pi carrier present in adult mouse 
liver, in the control of mitochondrial AdN 
levels and respiration in response to Ca2+ 
signals as a candidate target of glucagon 
actions. With the use of SCaMC-3 knock-
out (KO) mice, we have found that the 
carrier is responsible for the accumulation 
of AdNs in liver mitochondria in a strictly 
Ca2+-dependent way with an S0.5 for Ca2+ 
activation of 3.4 ± 1.9 μM. Accumulation of 
matrix AdNs allows SCaMC-3-dependent 
increase in CRC. In addition, SCaMC-3-
dependent accumulation of AdNs is 
required to acquire a fully active state 3 
respiration in AdN-depleted liver 
mitochondria, although further 
accumulation of AdNs is not followed by 
increases in respiration. Moreover, 
glucagon addition to isolated hepatocytes 
increases oligomycin-sensitive oxygen 
consumption and maximal respiratory 
rates in cells derived from wild type, but 
not SCaMC-3-KO mice and glucagon 
administration in vivo results in an 
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increase in AdN content, state 3 respiration 
and CRC in liver mitochondria in wild 
type but not in SCaMC-3-KO mice. These 
results show that SCaMC-3 is required for 
the increase in oxidative phosphorylation 
observed in liver mitochondria in response 
to glucagon and Ca2+-mobilising agents, 
possibly by allowing a Ca2+-dependent 
accumulation of mitochondrial AdNs and 
matrix Ca2+, events permissive for other 
glucagon actions. 
 
During fasting, glucagon secreted by 
α-cells in the pancreas activates a complex 
metabolic response in liver cells that includes 
glycogen breakdown, gluconeogenesis, urea 
synthesis, uptake of adenine nucleotides 
(AdNs) and increase in the Ca2+ retention 
capacity (CRC) of the  mitochondria, and 
stimulation of oxidative phosphorylation 
(OXPHOS) [1, 2]. Although the primary 
pathway of glucagon action involves binding 
of the hormone to a G-protein coupled 
receptor and formation of cAMP through 
activation of adenylate cyclase, a cytosolic 
Ca2+ signal is also produced both by release 
of intracellular stores and Ca2+ entry in the 
cell [3]. Inhibition of this Ca2+ signal has been 
shown to block the increase in mitochondrial 
AdN content after glucagon treatment [4], 
thereby reducing matrix availability for AdN-
dependent reactions, including OXPHOS [5]. 
Two different mechanisms have been 
proposed to mediate the mitochondrial uptake 
of AdNs by Ca2+. In the first one, entry of 
cytosolic Ca2+ into the mitochondria would 
inhibit the matrix pyrophosphatase, leading to 
an increase in pyrophosphate that would then 
be exchanged by cytosolic AdNs through the 
ATP/ADP translocase (ANT) [6]. The second 
mechanism, proposed by Aprille and co-
workers [7, 8], involves the ATP-Mg/Pi 
carrier, a Ca2+-dependent mitochondrial 
carrier that has been recently identified at the 
molecular level [9, 10].  
Due to its structure, with Ca2+-
binding EF-hand domains facing the 
intermembrane space, the ATP-Mg/Pi carrier 
is activated by Ca2+ signals that do not require 
entry of the cation in the mitochondria 
(reviewed in [11]). To date, five different 
paralogs, termed SCaMC (short calcium-
binding mitochondrial carrier) 1-3, -1like and 
-3-like, have been described in mammals [9, 
10, 12-14], of which two, SCaMC-1like and 
SCaMC-3like, are only expressed in testis. In 
addition, several splicing isoforms have been 
described [9], making it the most complex 
subgroup of mitochondrial carriers [15]. The 
transport activity catalysed by the SCaMCs is 
the electroneutral and reversible exchange of 
ATP-Mg2- or HADP2- with HPO42- [16]. 
Unlike the ANT, the ATP-Mg/Pi carrier does 
not interchange AdNs between the cytoplasm 
and the mitochondria, but rather increases or 
decreases the net mitochondrial AdN content. 
In this work we have studied the role 
of SCaMC-3/Slc25a23, the main paralog of 
the ATP-Mg/Pi carrier in liver, in 
mitochondrial function in response to Ca2+-
mobilising agonists glucagon and 
phenylephrine. With the use of SCaMC-3 
knock-out (KO) mice, we have found that the 
carrier is responsible for the accumulation of 
AdNs in liver mitochondria in a strictly Ca2+-
dependent way, with an S0.5 for Ca2+-
activation of 3.4 ± 1.9 µM, and that SCaMC-
3-dependent accumulation of AdNs is 
required to increase mitochondrial CRC and 
acquire a fully active state 3 respiration in 
liver mitochondria. Moreover, glucagon 
addition to isolated hepatocytes increases 
oligomycin-sensitive oxygen consumption in 
cells derived from wild type, but not 
SCaMC-3-KO mice, and in vivo glucagon 
administration results in an increase in AdN 
content, CRC and respiratory capacity in 
liver mitochondria, mediated by SCaMC-3. 
These results reveal an important role of 
SCaMC-3 as target of Ca2+-mobilising agents 




Animals- Mice deficient in SCaMC-3 
were generated by Lexicon with a mixed 
C57BL6/Sv129 genetic background. Animals 
are born in mendelian proportions and show 
no evident phenotypic traits. Genotyping was 
performed by double PCR using primers 9 
(forward; 5'-TGAGGCATGAGGCATATTC 
TA-3') and 10 (reverse; 5'-AAGGCTGTG 
AAACATGAGCA-3') to detect the wild type 
allele, and primers Neo3a (forward; 5'-
GCAGCGCATCGCCTTCTATC-3') and 12 
(reverse; 5'-GGGCTAGCTGTATTACCAG 
TC-3') to detect the targeted locus. Products 
were resolved by electrophoresis in 1.5% 
agarose gels and identified by their fragment 
sizes. All animal work performed in this study 
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was carried out in accordance with procedures 
approved in the Directive 86/609/EEC of the 
European Union and with approval of the 
Ethics Committee of the Universidad 
Autónoma de Madrid. Glucagon (2 mg/kg; 
Sigma-Aldrich, St. Louis, MO, USA) was 
injected intraperitoneally in fed 3-5 month-
old male mice and animals were sacrificed by 
cervical dislocation 15 min after 
administration.  
Metabolic measurements- Glucose 
was measured using a blood drop with 
Accutrend stripes. Blood serum was obtained 
from 2-3 month-old wild type and SCaMC-3-
KO mice and urea was measured using a 
commercial kit (Spinreact, Barcelona). 
Hepatocytes isolation and culture- 
Hepatocytes were isolated as previously 
described [17]. Briefly, livers from 12h-fasted 
3-5 month-old male mice were perfused with 
Hank's balanced salt solution supplemented 
with 10 mM Hepes and 0.2 mM EGTA for 5 
min, followed by a longer perfusion (10-15 
min) with William's medium E containing 10 
mM Hepes and 0.03% collagenase H (0.19 
U/mg; Sigma-Aldrich). Livers were further 
minced and viable hepatocytes were selected 
by centrifugation in Percoll, and seeded in 
collagen I-coated plates at a density of 0.6 x 
106 cells/cm2 in Dulbecco's modified Eagle 
Medium:F12 (1:1). Cells were kept overnight 
at 37ºC and 5% CO2, and used 12-16 hours 
later.  
Western blot and antibodies- Protein 
samples were collected in extraction buffer 
(250 mM sucrose, 1 mM EDTA, 1 mM 
EGTA, 25 mM Hepes, 10 mM KCl, 1.5 mM 
MgCl2, 1 mM DTT, 0.1% BSA , pH 7.4, 
containing protease inhibitors), disrupted by 
sonication and quantified. Samples were 
resolved in SDS-PAGE using 10% gels, 
transferred to nitrocellulose membranes and 
incubated with the indicated primary 
antibodies. Rabbit polyclonal antibodies 
against SCaMC-1, -2 and -3 were used at a 
dilution of 1:5,000, as previously described 
[9]. Mouse monoclonal Hsp60 antibody 
(Sigma-Aldrich) and rabbit polyclonal β-
ATPase antibody (a kind gift from Dr. J. M. 
Cuezva CBMSO) were used at a dilution of 
1:10,000. Peroxidase coupled secondary 
antibodies were used and proteins visualized 
with a chemiluminescence detection kit (ECL, 
PerkinElmer, Waltham, MA, USA). 
Mitochondria isolation- For oxygen 
consumption measurements and transport 
assays, liver mitochondria were isolated as 
previously described [18]. Final pellets were 
resuspended in MSK buffer (75 mM D-
mannitol, 25 mM sucrose, 5 mM KH2PO3, 20 
mM Tris-HCl, 0.5 mM EDTA, 100 mM KCl 
and 0.1% BSA fatty acids free, pH 7.4). 
Muscle mitochondria were extracted from 
hindlimbs in 100 mM sucrose, 9 mM EDTA, 
1 mM EGTA, 100 mM Tris-HCl, 46 mM 
KCl, pH 7.4 and incubated with protease 
Nagarse (0.4 mg/mL, 10 min; Sigma-Aldrich) 
prior to homogenization. For heart 
mitochondria, the procedure was the same as 
for muscle, but a different buffer was used 
(230 mM mannitol, 70 mM sucrose, 1 mM 
EDTA, 5 mM Tris-HCl, pH 7.4). 
ATP-Mg transport assays and AdN 
quantification- Transport assays were 
performed with 0.5 mg of mitochondria in 
transport medium (225 mM sucrose, 2 mM 
KH2PO4, 4 mM ATP, 5 mM MgCl2, 10 mM 
Tris-HCl, 200 nM ruthenium red (RR), 5 mM 
succinate, pH 7.4 at 30ºC in the presence of 1 
mM EGTA or 20 μM CaCl2 for different time 
lengths. The reactions were stopped by 
addition of 1.5 volumes of ice-cold transport 
medium devoid of succinate and 
supplemented with 1 mM EGTA. 
Mitochondria were centrifuged at 14,000g for 
5 min, and washed twice in the same medium. 
AdNs were extracted from pellets by 
incubation with 10% HClO4 for 60 min. 
Extracts were centrifuged and neutralized 
using KOH.  
To evaluate the Ca2+-dependency of 
the transport, wild type mitochondria were 
incubated in transport medium with different 
concentrations of CaCl2 for 5 min and 
processed as above. The different Ca2+ 
concentrations were prepared using EGTA-
Ca2+ buffers [19]. The free Ca2+ in each 
medium was determined, in the presence of 
mitochondria and all reactants with 0.1 μM 
Calcium-Green (Molecular Probes, 
Invitrogen, Eugene, OR, USA) using the 
equation [Ca2+] = Kd (F-Fmin)/(Fmax-F), where 
F is the fluorescence of the medium, while 
Fmax and Fmin are determined in each case by 
adding saturating amounts of CaCl2 (Fmax) or 
EGTA-Tris pH 8 (Fmin), and Kd is 14 μM 
[20]. Fluorescence was measured in a 
FluoSTAR OPTIMA microplate reader 
(λex/λem= 506/532 nm).  
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Total ATP was quantified using an ATP 
Bioluminiscence Assay Kit CLS II (Roche) 
with a FLUOstar OPTIMA microplate reader. 
ADP was measured by conversion to ATP 
using 2.5 mM phosphocreatine and 4 units of 
phosphocreatine kinase. AdN levels were also 
determined by HPLC. To this end, 
mitochondrial samples were treated with 10% 
HClO4 overnight, neutralized using K2CO3, 
kept on ice 10 min and then at -80ºC for 1 h 
to allow precipitation of HClO4. Extracts 
were centrifuged and 50 μL of the 
supernatants were injected for AdN 
determination [21]. To determine the identity 
of each peak and quantify the amount of the 
species of interest, standard curves were 
constructed by plotting peak heights versus 
known concentrations of ATP, ADP and 
AMP [22].  
Oxygen consumption measurements- 
Respiratory rates in isolated mitochondria 
were determined using a Clark-type oxygen 
electrode (Hansatech Instruments Ltd, 
Norfolk, UK) as described previously [23]. 
Measurements were performed at 30ºC in 
MSK buffer supplemented with 1 mM EGTA 
unless noted otherwise, using 0.3-0.4 mg 
protein. State 4 respiration was assayed in 5 
mM glutamate plus malate or 2 μM rotenone 
plus 5 mM succinate. State 3 was initiated by 
the addition of 0.5 mM or 2 mM ADP.  To 
confirm that state 3 was dependent on ATP 
synthase activity, 6 μM oligomycin was 
added to the mitochondrial suspension, which 
resulted in the same respiratory rates as 
before ADP addition. At the end of each 
assay, 1-5 μM Carbonyl cyanide-4- 
(trifluoromethoxy)phenylhydrazone (FCCP) 
was added to uncouple mitochondria and 
obtain maximal respiration, confirming 
membrane integrity With the exception of 
experiments using AdN-depleted 
mitochondria, uncoupled rates were similar to 
state 3 respiration as previously described 
[24]. Respiratory control ratios were obtained 
by dividing state 3 by state 4 respiratory rates, 
which were corrected by subtracting 
unspecific rates obtained before substrate 
addition.  
In some experiments mitochondria were 
depleted of AdNs by incubation in MSK with 
2 mM tetrasodium pyrophosphate for 5 min at 
30ºC [25, 26], centrifuged at 10,000g for 5 
min and resuspended in fresh MSK. AdN 
depletion was confirmed by measuring 
oxygen consumption in the presence of 1 mM 
EGTA, as depleted mitochondria are unable to 
stimulate respiration after ADP addition [7]. 
For the filling reactions with ATP-Mg, 
mitochondria were incubated in MSK devoid 
of EDTA and supplemented with 200 nM RR 
and the indicated concentrations of ATP and 
MgCl2, at 30ºC for different time lengths. The 
free Ca2+ concentration of the medium was 
determined fluorimetrically in the presence of 
mitochondria, all reactants and 0.1 μM 
Calcium-Green-5N. Incubations were stopped 
by introducing the samples in ice, centrifuged 
(10,000g, 5 min) and resuspended in the MSK 
with 1 mM EGTA for oxygen measurements 
or 10% HClO4 for AdN quantification.  
To assess oxygen consumption in intact 
attached cells, hepatocytes were plated in 
XF24 V7 cell culture plates and a Seahorse 
Bioscience XF24-3 Analyzer (Seahorse 
Bioscience, Billerica, MA, USA) was used as 
previously described [27]. Before 
measurements, cell medium was replaced by 
assay medium (bicarbonate-free DMEM: F12 
(1:1) supplemented with 10 mM sodium 
lactate and 5 mM glucose) and plates were 
equilibrated at 37ºC for 60 min. After 
baseline measurement, one of the following 
agonists was injected: 0.1 μM glucagon 
(Sigma-Aldrich), 100 μM phenylephrine 
(Sigma-Aldrich) or vehicle. Subsequently, all 
wells were injected sequentially with 6 μM 
oligomycin, 1 μM FCCP and 1 μM antimycin 
A plus 1 μM rotenone to obtain different 
respiratory parameters. 
Cytochrome c oxidase activity. The 
activity of cytocrome c oxidase was measured 
in MSK using 10-20 μg of mitochondria and 
following the decrease in absorbance at 550 
nm of 25 μM cytochrome c, which was 
previously reduced using sodium dithionite, 
essentially as previously described [28]. 
Ca2+ uptake in isolated mitochondria- 
The CRC of isolated mitochondria was 
measured with 0.1 μM Calcium Green-5N as 
an extra-mitochondrial Ca2+ indicator in MSK 
devoid of EDTA and supplemented with 1 
mM MgCl2 as previously described [29]. An 
Aminco-Bowman fluorimeter provided with 
temperature control and continuous stirring 
was used. All experiments were carried out at 
30ºC in the presence of respiratory substrates 
(5 mM succinate + 2 μM rotenone) and in the 
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presence or absence of AdNs (ATP or ADP). 
After 3-5 min of incubation, mitochondria 
were challenged with subsequent 10-20 nmol 
CaCl2 additions as indicated in the figure 
legends, and Ca2+ uptake into mitochondria 
was measured as a decrease in fluorescence. 
The CRC was determined as the total amount 
of Ca2+ (in nmol per mg of protein) that the 
mitochondria are able to take up before 
starting to release it to the extra-mitochondrial 
medium. 
Cytosolic Ca2+ measurements- To 
monitor cytosolic Ca2+ signals, hepatocytes 
growing on coverslips were loaded with 5 μM 
Fura-2-AM (Molecular Probes, Invitrogen) 
for 15 min at 37ºC in Ca2+-free HCSS 
medium (120 mM NaCl, 0.8 mM MgCl2, 25 
mM Hepes and 5.4 mM KCl) supplemented 
with 0.05% pluronic acid F-127 (Invitrogen) 
and washed for 20 min at 37ºC in HCSS with 
2 mM CaCl2. Coverslips were then mounted 
in the perfusion chamber of a Zeiss 
microscope as previously described [30], and 
fluorescence was imaged ratiometrically at 
37ºC using alternate excitation at 340 and 380 
nm and a 510-nm emission filter with a 
Neofluar 40X/0.75 objective. Agonists were 
added as a bolus. Image acquisition and 
analysis were performed using Aquacosmos 
2.6 software (Hamamatsu Photonics, 
Hamamatsu, Japan). Ratio signals were 
converted to Ca2+ concentrations using the 
calculations described in [20]. 
 
RESULTS  
SCaMC-3 is the only functional ATP-
Mg/Pi carrier in adult liver- SCaMC-3-KO 
and SCaMC-3 heterozygous mice are born in 
mendelian proportions and have no obvious 
phenotype, similar to what has been described 
for SCaMC-2-KO mice [31]. Table 1 shows 
that SCaMC-3-KO mice have normal glucose, 
but reduced plasma urea levels.  
To study whether a compensatory 
effect is taking place in SCaMC-3-KO 
animals, we analysed the protein levels of the 
other paralogs of the ATP-Mg/Pi carrier in 
mitochondria from different adult tissues. 
SCaMC-3 signal was found in liver and brain, 
but not in heart or muscle mitochondria 
(Figure 1A) whereas SCaMC-2 and SCaMC-
1 were only detected in brain, but not liver. 
There was no up-regulation of either of these 
paralogs in mitochondria from SCaMC-3-KO 
mice. SCaMC-3 levels in late embryonic and 
early postnatal liver are much lower than in 
adult liver (Figure 1B). At these stages, 
SCaMC-1 showed high levels from E14-E18 
until P1, being almost negligible in adult 
liver, whereas SCaMC-2 expression was not 
detected (results not shown). Again, no 
changes in SCaMC-1 levels were detected in 
embryonic liver mitochondria from SCaMC-
3-KO mice. 
To study the effect of the lack of 
SCaMC-3 in mitochondrial respiration, liver 
mitochondria from wild type and SCaMC-3-
KO mice were incubated with 5 mM 
glutamate plus malate or 2 μM rotenone plus 
5 mM succinate in a Ca2+-free medium, in the 
absence or presence of 0.5 mM ADP. 
Respiratory rates in all conditions, as well as 
respiratory control ratios, were similar in both 
genotypes, indicating lack of abnormalities in 
electron transport chain activity and 
OXPHOS in SCaMC-3-deficient 
mitochondria (Figure 1C). 
SCaMC-3 catalyses the transport of 
ATP-Mg in isolated liver mitochondria in a 
Ca2+-dependent way- SCaMC-3 has been 
shown to transport ATP-Mg and ADP in 
exchange with Pi in reconstituted 
proteoliposomes, but the Ca2+ dependency of 
this transport has not been characterised [10]. 
We performed transport assays incubating 
wild type and SCaMC-3-KO liver 
mitochondria with 4 mM ATP for different 
time lengths. Wild type mitochondria show a 
time-dependent accumulation of ATP which 
requires Ca2+, as it does not take place when 
EGTA is present in the medium (Figure 1D, 
left panel). No ATP accumulation is observed 
in SCaMC-3-deficient mitochondria, 
regardless of whether Ca2+ is present or not 
(Figure 1D, left panel). These results indicate 
that the transport of ATP-Mg in liver 
mitochondria is catalysed by SCaMC-3 by a 
mechanism that requires Ca2+. In another set 
of experiments the Ca2+ affinity of ATP-Mg 
uptake was studied by carrying out assays at 
different external Ca2+ concentrations. An S0.5 
for Ca2+ activation of 3.4 ± 1.9 μM was 
obtained (Figure 1D, right panel). In both 
experiments RR was present in the medium to 
prevent Ca2+ entry in the mitochondria. 
CRC is impaired in SCaMC-3-
deficient mitochondria. In the case of 
SCaMC-1, the mitochondrial ATP-Mg/Pi 
transporter found in cancer cells, the uptake 
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of AdNs through the carrier dramatically 
increases Ca2+ retention in mitochondria [29]. 
Therefore, we wondered if the absence of 
SCaMC-3 affects CRC in mitochondria.  To 
test this possibility, liver mitochondria from 
wild type and SCaMC-3-KO animals were 
incubated in the absence of AdNs or in the 
presence of ATP-Mg or ADP at low (0.2 
mM) or physiological (1 mM) concentrations 
(Figure 2). In the absence of AdNs, the CRC 
is similar in both genotypes, and so is the 
Ca2+ uptake rate (notice the identical slopes 
after Ca2+ addition). Addition of 0.2 mM ADP 
(or ATP-Mg, not shown) to the medium 
substantially increases the CRC of 
mitochondria in both genotypes, most likely 
by a mechanism mediated by the ATP/ADP 
carrier [32]. However, when 1 mM ATP-Mg 
(or ADP, not shown) is present in the 
medium, wild type mitochondria show a 
marked increase in the CRC, with no changes 
in the initial Ca2+ uptake rates, whereas 
SCaMC-3-deficient mitochondria are unable 
to accumulate higher amounts of Ca2+. 
 
ATP-Mg or ADP uptake in AdN-
depleted mitochondria regulates coupled 
respiration through extra-mitochondrial 
Ca2+-dependent SCaMC-3 activity- 
Alterations in the mitochondrial AdN pool 
have been shown to regulate state 3 
respiration in liver mitochondria [25]. 
Incubation with high concentrations of 
pyrophosphate promotes the efflux of matrix 
ATP, ADP and AMP in exchange with 
external pyrophosphate through the 
ATP/ADP translocase, leading to a depletion 
of mitochondrial AdNs [25, 26]. In these 
conditions, state 4 is increased [33], state 3 
cannot be induced due to the lack of matrix 
ATP to be exchanged by external ADP 
through the ANT, and only the net uptake of 
ADP or ATP, both of which are transported 
by the ATP-Mg/Pi carrier, can restore 
coupling between electron transport activity 
and OXPHOS [25]. 
To study the influence of SCaMC-3-
mediated AdN uptake on ADP-stimulated 
respiration we first depleted mitochondria 
from AdNs by incubation with 
pyrophosphate, and then evaluated oxygen 
consumption. In the presence of extra-
mitochondrial Ca2+ (~3-4 μM), addition of 2 
mM ADP stimulates oligomycin-sensitive 
respiration in AdN-depleted mitochondria 
from wild-type but not SCaMC-3-KO mice 
while no differences are observed in 
uncoupled respiration between genotypes 
(Figure 3A). Matrix Ca2+ is not required, as 
the effect is observed in the presence of 200 
nM RR to inhibit Ca2+ uptake by the 
mitochondria. However, extra-mitochondrial 
Ca2+ is strictly required for the stimulation, as 
addition of 2 mM ADP in the presence of 1 
mM EDTA and 1 mM EGTA fails to induce 
state 3 respiration (Figure 3B). In these last 
condition (i.e. AdN-depleted mitochondria in 
Ca2+-free medium), state 4 respiratory rates 
are increased as previously described [33], 
both in wild type and SCaMC-3-deficient 
mitochondria. However, stimulation of the 
respiration can still be achieved, as 
mitochondria increase their respiratory rates 
in response to FCCP (Figure 3B). Taken 
together, these results indicate that matrix 
AdNs are required to achieve state 3 but not 
fully uncoupled respiration. 
Although the ATP-Mg/Pi carrier can 
transport both ATP-Mg and ADP in isolated 
mitochondria and reconstituted liposomes, it 
has been shown that ATP-Mg is the preferred 
substrate under normal energized conditions, 
as the cytosolic ATP concentration exceeds 
that of ADP [34]. To study the respiratory 
effect of ATP-Mg uptake in AdN-depleted 
mitochondria, these were incubated at 30ºC in 
the presence of 2 mM ATP, 5 mM MgCl2 and 
200 nM RR for different time lengths, and 
then the ADP-response to oxygen 
consumption in the presence of 1 mM EGTA 
was evaluated. After 1 minute of incubation, 
wild type but not SCaMC-3-KO mitochondria 
showed a slight non-significant decrease in 
state 4 respiratory rates (Figure 4A, state 4) 
and an increase in state 3 respiration, which 
was maximum after 2 minutes (Figure 4A, 
state 3). This is reflected in a gradual increase 
in respiratory control ratios, but not in 
uncoupled respiration (Fig 4A uncoupled), 
which occurs in wild type but not SCaMC-3 
deficient mitochondria (Figure 4A, RCR,). 
These results indicate that extra-
mitochondrial Ca2+-dependent AdN uptake 
through SCaMC-3 couples electron transport 
chain activity and OXPHOS in isolated 
mitochondria after AdN depletion. 
To study the consequences of ATP-
Mg uptake in normal, non-depleted 
organelles, liver mitochondria from wild type 
and SCaMC-3-KO mice were incubated with 
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10 mM ATP and 10 mM Mg2+ in the presence 
of 5 mM succinate and 200 nM RR, washed 
and assayed for ADP + ATP content and 
respiration. As observed in Figure 3B, this 
resulted in a rapid increase in matrix ADP + 
ATP in both genotypes, but much lower in 
SCaMC-3-KO than in wild type 
mitochondria. These results emphasize the 
role of SCaMC-3 in AdN “superfilling” and 
suggest that under these conditions, other 
transport processes (including 
pyrophosphatein/AdNout exchange on ANT) 
contribute to refilling.  
In contrast with the results on AdN-
depleted mitochondria, despite the large 
increase in the AdN pool, state 3 and 4 and 
uncoupled respiratory rates were unchanged 
regardless of the presence of SCaMC-3 
(Figure 4B).  
Glucagon and phenylephrine exert 
their effects on mitochondrial respiration 
through SCaMC-3- Having shown that 
SCaMC-3 is able to induce an increase in 
liver mitochondrial AdN content and coupled 
respiration that does not occur in SCaMC-3-
KO mitochondria, we next studied whether 
this mechanism is responsible for the 
glucagon-stimulation of mitochondrial 
respiration in hepatocytes [2]. The stimulation 
by glucagon of AdN uptake in liver 
mitochondria is dependent on the generation 
of a Ca2+ signal [4]. Similarly, Ca2+-
mobilising agents like phenylephrine have 
been shown to increase the mitochondrial 
AdN content in hepatocytes [35]. In each 
case, the nature of the Ca2+ signals evoked is 
different and both agonists are known to be 
synergistically potentiated [36]. Figure 4A 
shows the effect of these agonists on cytosolic 
Ca2+ in isolated hepatocytes using fura2-AM. 
Transients elicited by 0.1 μM glucagon show 
a delayed onset of about 2 minutes (Figure 
5A), whereas addition of 100 μM 
phenylephrine induces an immediate increase 
in cytosolic Ca2+ (Figure 5A). In both cases, 
cells that show spontaneous oscillatory 
behaviour before the addition increase their 
oscillation frequency, whilst most of the non-
oscillatory cells start to oscillate (data not 
shown). No differences were observed 
between genotypes.  
We next studied the effect of 
glucagon and phenylephrine on the oxygen 
consumption rate (OCR) of intact primary 
hepatocytes using a Seahorse Extracellular 
Flux Analyzer. Experiments were performed 
using the layout represented in Figure 5B. 
Both genotypes showed similar basal rates 
normalised by protein content (1.9 ± 0.7 
nmol/min/mg in wild type cells vs 1.7 ± 0.6 
nmol/min/mg in SCaMC-3-deficient cells). 
Both glucagon and phenylephrine cause an 
immediate stimulation of the OCR in wild 
type cells of about 20% with respect to 
vehicle, which is significantly lower (about 
5%) in SCaMC-3-KO hepatocytes (Figure 5C 
and 5D, agonist-induced stimulation). In wild 
type cells most of this stimulation is due to an 
increase in coupled respiration (i.e. 
oligomycin sensitive), particularly in the case 
of glucagon, whereas neither of the two 
agonists increase coupled respiration in 
SCaMC-3-KO cells (Figure 5D, coupled 
respiration). Glucagon also induces an 
increase of about 20% in the maximal 
respiratory capacity (i.e. FCCP-stimulated 
respiration) in hepatocytes from wild type 
mice, but not in those from SCaMC-3-KO 
mice (Figure 5C and 5D, maximal respiratory 
capacity). Phenylephrine effects on maximal 
respiratory capacity and coupled respiration 
followed the same trend but did not reach 
statistical significance. Neither glucagon nor 
phenylephrine have a significant effect on 
proton leak values in any of the genotypes 
(Figure 5D, proton leak). Taken together, 
these results show that glucagon and 
phenylephrine induce a rapid increase in 
mitochondrial respiration from intact primary 
hepatocytes (particularly coupled respiration) 
and that this effect is largely lost in 
hepatocytes that lack SCaMC-3. 
AdN uptake, CRC and stimulation of 
respiration in mitochondria after glucagon 
treatment in vivo is mediated by SCaMC-3- 
To verify that the effects found in isolated 
mitochondria and primary hepatocytes are 
also present in the intact animal, we next 
studied the effect of in vivo administration of 
glucagon, which has been shown to promote 
uptake of AdNs and to stimulate respiration in 
liver mitochondria [4, 37, 38]. To study the 
involvement of SCaMC-3 in this hormonal 
response, we injected glucagon 
intraperitoneally in wild type and SCaMC-3-
KO mice and sacrificed them 15 minutes later 
to analyse liver mitochondrial AdN content 
and respiratory rates. Figure 5A shows that 
liver mitochondria from wild type mice 
undergo a striking increase of about 50% in 
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their AdN levels in response to glucagon 
treatment while the levels in SCaMC-3-KO 
mitochondria remain unaffected by the 
treatment. The increase is not restricted to a 
particular AdN form, but rather affects all 
three: AMP, ADP and ATP (Figure 6A, right 
panel). Interestingly, under control (vehicle) 
conditions, ATP levels were found to be 
lower in SCaMC-3-KO than in wild type 
mitochondria. Although extraction procedures 
do no warrant that these concentrations 
correspond to the real levels of the three 
AdNs in vivo, they suggest that SCaMC-3 
deficiency might involve a decrease in 
mitochondrial ATP levels. In fact, mouse 
embryonic fibroblast derived from SCaMC-2-
KO mice show lower cellular ATP levels 
[31]. 
In liver of fed rats, glucagon 
administration also leads to a rapid increase in 
the CRC [39] and Ca2+ content [40] of rat 
liver mitochondria. The increase in 
mitochondrial Ca2+ plays a role in activation 
of mitochondrial dehydrogenases and 
regulation of respiration [41]. Having found 
that SCaMC-3 is required to increase CRC in 
response to AdN accumulation, we evaluated 
whether SCaMC-3 may be also involved in 
increasing the CRC of mitochondria in 
response to glucagon. Figure 6B shows that 
glucagon treatment results in a prominent 
increase in CRC in liver mitochondria from 
wild type mice (compare Figure 2A with 
Figure 6B), which is essentially blunted in 
SCaMC-3-deficient mitochondria. This 
suggests that increased CRC in mitochondria 
could be involved in the increase in 
respiratory capacity observed after glucagon 
treatment. 
Fig 6C also shows that glucagon 
administration in vivo results in a 40% 
increase in state 3 respiratory rates of wild 
type mitochondria incubated with succinate 
and a similar trend for uncoupled respiration, 
but has no effects in SCaMC-3-KO liver 
mitochondria. Complex IV activity is not 
stimulated by glucagon in wild type or 
SCaMC-3-deficient mitochondria (Figure 
6D), as previously described [42, 43]. 
Therefore, the lack of SCaMC-3 
blocks the responses of liver mitochondria to 
glucagon in vivo, preventing AdN 





We have shown that SCaMC-3 is the 
main mitochondrial ATP-Mg/Pi transporter in 
adult liver from mice. We find that SCaMC-3 
has an S0.5 for Ca2+ activation of 3.4 ± 1.9 
µM, a value substantially lower than that of 
SCaMC-1 (12.7 ± 5.3 µM) [29] or the yeast 
ATP-Mg/Pi carrier, Sal1p (17.4 ± 0.7 µM) 
[19]. Ca2+ increases the Vmax of these 
carriers with no changes in the Km for the 
substrates, which are similar for both ATP-Mg 
and ADP in all cases, ranging 0.2-0.5 mM 
[10]. 
Previous studies have shown that the 
filling of the mitochondria with cytosolic 
AdNs during the first postnatal hours is 
important in the liver adaptation to an aerobic 
environment [44]. However, despite the fact 
that SCaMC-3 is the main paralog of the 
carrier in adult liver, SCaMC-3-KO mice are 
born in mendelian proportions, do not show 
obvious developmental defects and lack 
compensatory effects caused by up-regulation 
of other mitochondrial transporters of ATP-
Mg/Pi. This may be explained by our finding 
that SCaMC-1 and SCaMC-3 are both co-
expressed in the embryonic and early 
postnatal liver, and therefore, SCaMC-1 may 
compensate for the lack of SCaMC-3 during 
postnatal development.  
Glucagon is known to exert multiple 
effects on liver mitochondria  including the 
increase in AdN content, respiration and 
CRC, as well as enhanced synthesis of 
citrulline and pyruvate carboxylation [41]. 
Regarding the first of these effects, our results 
have clarified how glucagon and 
phenylephrine cause an increase in 
mitochondrial AdN content. To date, two 
hypotheses had been proposed: in the first 
one, Halestrap and co-workers suggested that 
the entry of Ca2+ in the mitochondria could 
inhibit matrix pyrophosphatase, leading to an 
increase in matrix pyrophosphate that would 
then be exchanged by cytosolic AdNs through 
the ANT [6]. The second mechanism, put 
forward by Aprille’s group, involves the Ca2+-
activation of the ATP-Mg/Pi carrier [2, 7]. 
Our data clearly support this latter hypothesis, 
showing that the increase in liver 
mitochondrial AdNs in response to glucagon 
does not take place in the absence of SCaMC-
3 (Figure 6B), which is the only functional 
ATP-Mg/Pi carrier in adult liver (Figure 1). 
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Moreover, the present work also 
sheds light on the effect of glucagon on 
mitochondrial CRC and its relation with 
mitochondrial AdN content. In agreement 
with previous findings related to SCaMC-1 
[29] our results show that Ca2+ activation of 
AdN uptake through SCaMC-3 causes an 
accumulation of matrix AdNs which increases 
mitochondrial CRC. This may be due to the 
formation of Ca2+-phosphate precipitates, as 
this process requires AdNs [45]. Moreover, 
SCaMC-3 deficiency prevents the increase in 
CRC caused by glucagon administration, 
showing that this effect of glucagon is 
mediated by SCaMC-3. 
We have shown that SCaMC-3 can 
regulate oxidative phosphorylation under 
certain conditions. We report a striking effect 
of SCaMC-3 mediated Ca2+-dependent uptake 
of ADP or ATP-Mg in liver mitochondria 
which effectively couples respiration and 
OXPHOS, most likely by increasing the total 
mitochondrial AdN pool. Previous studies 
have shown a biphasic correlation between 
mitochondrial AdN content and respiratory 
functions, which is especially steep when 
matrix AdN levels are below 4 nmol/mg 
protein, but becomes more moderate at higher 
concentrations [25]. Our own results confirm 
this dependency on the size of the AdN pool 
of state 3 respiration at relatively low matrix 
AdN levels (Figure 4A) but not at higher AdN 
levels (Figure 4B). It is important to note that 
RR was present in these experiments, ruling 
out an effect of matrix Ca2+. Therefore, it is 
likely that the stimulation of respiration 
observed by progressively increasing the AdN 
content is due to direct mass-action ratio 
effects of ADP and ATP on the ATP synthase 
and/or the ANT. This stimulation may be 
important in situations where mitochondrial 
AdN levels are low, like in newborn liver and 
ischemic mitochondria, where even small 
changes in the mitochondrial AdN content 
may bring about significant changes in 
respiratory rates coupled to ATP synthesis, as 
previously suggested by Aprille [5]. 
However, the mechanism whereby an 
increase in mitochondrial AdN content will 
increase coupled and maximal respiration in 
the healthy adult liver, as occurs after 
treatment with glucagon, is unclear. As 
mentioned above, our results show that 
beyond a certain threshold, further 
accumulation of adenine nucleotides does not 
affect respiration rates. This contrasts sharply 
with the consequences of the stimulation by 
glucagon in intact hepatocytes and in vivo, 
where an increase in matrix AdN content is 
associated with an increase both in coupled 
and maximal uncoupled respiration, and a 
pronounced increase in respiratory capacity in 
isolated mitochondria, all of which require the 
presence of SCaMC-3.  
The stimulation of respiration by 
glucagon has been the subject of a great 
amount of work during the decades of the 70s 
and 80s, although the site of action of the 
hormone remains unknown. The enhancement 
of oxygen consumption is observed when the 
electron transport chain is fuelled with 
substrates of complex I or complex II, but not 
when TMPD plus ascorbate are used instead 
[42]. It has been concluded that glucagon-
induced activation of respiration involves 
increases in electron flow into the ubiquinone 
pool and within complex III [46, 47]. The 
mechanism proposed for such stimulation is a 
moderate increase in matrix volume caused 
by the uptake of Ca2+ into the mitochondria 
following glucagon-induced cytosolic Ca2+ 
signals. By inhibiting mitochondrial 
pyrophosphatase activity, matrix Ca2+ would 
cause an increase in pyrophosphate, in 
addition to induce a K+ influx into the 
mitochondria through a K+ uniporter whose 
nature is still debated [48]. Matrix Ca2+ itself 
may control coupled respiration through 
matrix Ca2+ activation of ATP synthase [49].  
Therefore, it is possible that the 
increase in mitochondrial CRC conferred by 
SCaMC-3 could explain the role of SCaMC-3 
in glucagon signalling. By allowing Ca2+ 
accumulation in mitochondria in vivo, 
SCaMC-3 might by permissive for K+ entry, 
pyrophosphate accumulation in mitochondria, 
and/or other glucagon targets, which would in 
turn modulate the increase in matrix volume 
and stimulate respiration [41]. 
A reduced CRC in mitochondria 
could also explain the different responses to 
glucagon and phenylephrine in SCaMC-3 
deficient hepatocytes. Whereas glucagon does 
not affect coupled or maximal respiration, 
phenylephrine tends to lower both parameters 
in these cells. Phenylephrine-induced Ca2+  
signals arise faster (Fig 5A), are more 
persistent in time [50] and give rise to larger 
changes in light scattering in isolated 
hepatocytes than those of glucagon [47, 51], 
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indicative of higher requirement for CRC in 
mitochondria than for glucagon. It is feasible 
that under these conditions, impaired Ca2+ 
retention in SCaMC-3-deficient mitochondria 
may hamper the respiratory response to 
phenylephrine.  
Interestingly, the present study 
provides indications that SCaMC-3 is also 
required for the operation of the urea cycle. 
Glucagon increases urea synthesis by 
activation of carbamoyl-phosphate synthetase, 
a limiting step in this process [47], and it has 
been proposed that increased ATP synthesis 
in mitochondria may account for this effect of 
glucagon [5]. The drop in blood serum urea 
levels found in SCaMC-3 KO mice (Table I), 
suggests  a limited function of  the urea cycle 
in SCaMC-3 deficiency which may associated 
with a decreased content of mitochondrial 
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Figure 1. SCaMC-3 is the main functional Ca2+-dependent ATP-Mg/Pi carrier in adult 
liver. (A) Expression levels of the main SCaMC paralogs were analysed by western blot in 
isolated mitochondria using different tissues from wild type (WT) and SCaMC-3-KO (KO) 
mice. β-ATPase was used as loading control. (B) Western blot analysis of liver extracts from 
embryos (E14-E17), postnatal (P0-P4) and 3 month old mice (3 mo) from wild type and 
SCaMC-3-KO mice. Antibodies against SCaMC-1 and SCaMC-3, as well as Hsp60 as loading 
control, were used. Absence of SCaMC-3 did not induce up-regulation of other ATP-Mg/Pi 
paralogs. (C) Respiratory rates were measured in isolated liver mitochondria from wild type and 
SCaMC-3-KO mice using substrates for complex I (glu+mal) or complex II (succinate) in the 
presence (state 3, st. 3) or absence (state 4, st. 4) of 0.5 mM ADP. Respiratory control ratios 
(state 3/state 4; RCR) using substrates for complex I or complex II are also shown. Results are 
expressed as mean ± S.E.M. of 8 (complex I) and 22 (complex II) independent experiments. (D) 
SCaMC-3 transports ATP-Mg in a Ca2+-dependent way. Left panel shows ATP uptake in 
isolated liver mitochondria from wild type and SCaMC-3-KO mice in the presence or absence 
of Ca2+. Mitochondria were incubated at 30ºC in the presence of 4 mM ATP, 5 mM Mg2+ and 
200 nM RR, with 20 μM Ca2+ or 1 mM EGTA in the medium, and mitochondrial ATP levels 
were determined. Results are expressed as mean ± S.E.M. of 3 independent experiments. In the 
right panel, kinetics of Ca2+ activation of ATP uptake in SCaMC-3 wild type liver mitochondria 
are shown. Data obtained were fitted by non-linear regression to the following equation V=V0 + 
[((Vmax-V0) x [Ca2+]N)/(S0.5N+[Ca2+]N)] (where V is transport activity at each [Ca2+], V0 is the 
basal transport rate at 0 [Ca2+] (i.e, below the Calcium-Green detection limit), Vmax is the 
maximal activity, N is the Hill index and S0.5 is the Ca2+ concentration which generates half-
maximal transport activity) using the Sigma Plot v.9. Pooled data from 5 independent 
experiments are shown.  
 
Figure 2. SCaMC-3 mediates the increase in Ca2+ retention capacity in liver mitochondria. 
Mitochondrial Ca2+ uptake was monitored using the fluorescent indicator Calcium Green 5N in 
the absence of AdNs in the medium (A) or in the presence of 0.2 mM ADP (B) or 1 mM ATP-
Mg (C). Arrows indicate additions of 20 nmol CaCl2. Quantification of total Ca2+ retained by 
mitochondria in each case is shown on the right side of each panel. Results are expressed as 
mean ± S.E.M. of 3-5 independent experiments. (*p<0.05; unpaired, two-tailed Student t). 
 
Figure 3. Addition of ADP to AdN-depleted mitochondria stimulates respiration through 
SCaMC-3. Representative electrode traces and respiratory rates of AdN-depleted liver 
mitochondria from wild type (WT) and SCaMC-3-KO mice respiring on succinate and 
stimulated with 2 mM ADP in the presence of Ca2+ (A) or in the presence of 1 mM EGTA and 
1mM EDTA (B). State 3 respiratory rate and respiratory control ratio (RCR) are only stimulated 
in wild type liver mitochondria in the presence of extra-mitochondrial Ca2+. Results are 
expressed as mean ± S.E.M. of 3-5 independent experiments. (*p<0.05; **p<0.01; WT vs KO 
two-tailed, unpaired Student t; #p<0.05; ##p<0.01; state 3 vs uncoupled two-tailed, paired 
Student t). Scale bars: 10 nmol O (vertical), 1min (horizontal). 
 
Figure 4. Respiration in mitochondria loaded with AdNs. (A) Wild type (WT) and SCaMC-
3-KO (KO) mitochondria were depleted from AdNs and incubated at 30ºC in the presence of 
200 nM RR, 2 mM ATP, and 5 mM MgCl2 for different time lengths before monitoring state 4, 
state 3 and uncoupled respiratory rates in the presence of 2 μM rotenone plus 5 mM succinate.  
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Respiratory control ratios (RCR) are also shown. Maximal increase of state 3 respiratory rate is 
observed in wild type cells after 2 min of incubation. Results are expressed as mean ± S.E.M. of 
5 independent experiments (*p<0.05; **p<0.01; two-tailed, unpaired Student t). (B) Non-
depleted wild type (WT) and SCaMC-3-KO (KO) mitochondria were incubated at 30ºC in the 
presence of 200 nM RR, 10 mM ATP, 10 mM MgCl2 and 20 μM CaCl2 at different times before 
monitoring state 4, state 3 and uncoupled respiratory rates as in (A). To correct for residual 
AdNs in the medium, state 4 was that obtained after the addition of oligomycin. In parallel, 
mitochondrial levels of ATP + ADP were also determined (bottom panel). Results are expressed 
as mean ± S.E.M. of 3-5 independent experiments (*p<0.05, two-tailed, unpaired Student t). 
 
Figure 5. Effects of glucagon and phenylephrine on cytosolic Ca2+ signals and respiratory 
parameters in primary hepatocytes from wild type and SCaMC-3-KO animals. (A) 
Representative traces corresponding to cytoplasmic Ca2+ concentration in primary wild type 
hepatocytes in response to 0.1 μM glucagon and 100 μM phenylephrine addition. Light grey 
traces correspond to individual cells, while the average is represented by a black trace. In both 
genotypes phenylephrine caused an immediate Ca2+ peak, whereas the effect of glucagon was 
detectable 2 min after its addition. The Ca2+ signals evoked by both agonists were identical in 
SCaMC-3-KO cells. (B) A representative experiment of OCR in primary hepatocytes from wild 
type and SCaMC-3-KO and the response to phenylephrine is shown. OCR is expressed as the 
rate at each point with respect to the basal rate at the time of addition of the agonist. Where 
indicated, 100 μM phenylephrine, 6 μM oligomycin, 1 μM FCCP and 1 μΜ rotenone plus 1 μM 
antimycin A (rot + AntA) were injected. (C) OCR responses to phenylephrine (100 μM) and 
glucagon (0.1 μM) and corresponding vehicle in hepatocytes from wt and SCaMC-3 KO mice. 
Data correspond to representative experiments. (D) Respiratory parameters after treatment with 
0.1 μM glucagon or 100 μM phenylephrine with respect to vehicle in wild type and SCaMC-3-
KO hepatocytes.  Non-mitochondrial respiration (the lowest value remaining after rotenone plus 
antimycin A addition) was subtracted from all measurements after confirming that at longer 
times respiration was not further decreased. Respiratory parameters were calculated as the 
average of three consecutive measurements after each addition (agonist, oligomycin, FCCP). 
The stimulations of glucagon and phenylephrine and maximal respiratory capacity were 
calculated as the percentage of respiration after agonist or FCCP addition with respect to basal 
respiration. Coupled respiration is the percentage of respiration in the presence of agonist 
sensitive to oligomycin inhibition. Proton leak was calculated as the difference between 
oligomycin-sensitive and non-mitochondrial respiration. Results are expressed as mean ± 
S.E.M. of 3 independent experiments with four replicates each (*p<0.05; **p<0.01; unpaired, 
two-tailed Student t, WT vs KO; # p<0.01 ## p<0.001 two-tailed Student t, WT vs vehicle). 
 
Figure 6. SCaMC-3 mediates glucagon-stimulated mitochondrial uptake of AdNs and 
increase in CRC and respiratory activity in vivo. Following in vivo administration of 
glucagon (2 mg/kg) or vehicle, liver mitochondria from wild type and SCaMC-3-KO mice were 
rapidly isolated and assayed for AdN content, measured by HPLC (A), CRC in isolated 
mitochondria in the absent of and (B), respiration with succinate (C) and cytochrome c oxidase 
activity (C). Results are expressed as mean ± S.E.M. of 3-5 independent experiments. (*p<0.05; 
WT vs KO, two-tailed, unpaired Student t; #p<0.05; WT vehicle vs WT glucagon, one-tailed, 













Table 1. Glucose and urea levels from wild type and SCaMC-3-KO mice. Levels were 
determined in 2-3 month-old mice as indicated in Materials and methods. Results are expressed 




 SCaMC-3 WT SCaMC-3 KO 
Glucose (mg/dL) 211.5 ± 7.8 196.2 ± 7.0 
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